Stanford Cancer Institute News

Fall 2017

Robert Negrin, MD, Professor and Chief of the Department of Medicine-BMT, co-leader of the SCI’s Immunology and Immunotherapy Research Program, SCI member

30 Years of BMT

The Stanford Blood and Marrow Transplant (BMT) Program celebrates 30 years of treating patients this fall. The program—the largest in Northern California—has been the designated provider for Kaiser Permanente in Northern California for over 20 years. It is also one of 20 programs nationwide to be named a Core Clinical Center for the NCI’s Blood and Marrow Transplant Clinical Trials Network.

Since Karl Blume, MD, founded the program in 1987, the team has developed the program into a national leader in offering patients the most efficacious treatment while managing and minimizing potentially life-threatening side effects. It is also a recognized leader in advancing science in the BMT field.

“On November 2, 1987, the first adult patient received a bone marrow transplant at Stanford,” noted Robert Negrin, MD, Professor and Chief of the Department of Medicine-BMT, and co-leader of the SCI’s Immunology and Immunotherapy Research Program. “We joined our former patient in celebrating the 30th anniversary of that important day. Since then, over 7,000 other patients have received life-saving transplants by our outstanding team, who provide the most scientifically rigorous and compassionate care possible. Our team is very proud of what we have accomplished. We are also humbled by the many patients and their families who entrust their care to us at a most critical time in their lives.”